Haleos Labs Limited (HALEOSLABS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002809,
    "name": "Haleos Labs Limi",
    "stock_name": "Haleos Labs Limi",
    "full_name": "Haleos Labs Limited",
    "name_url": "stocks-analysis/haleos-labs-limi",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,300.00",
    "chg": 1,
    "chgp": "0.08%",
    "dir": 1,
    "prev_price": "1,299.00",
    "mcapval": "393.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540679,
    "symbol": "HALEOSLABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE320X01016",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": "712 ",
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/haleos-labs-limi-1002809-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-upgraded-to-hold-as-technicals-improve-and-valuation-attracts-3945280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_mojoScore_3945280.png",
        "date": "2026-04-14 08:42:09",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 13 April 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors."
      },
      {
        "title": "Haleos Labs Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3939007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_mojoScore_3939007.png",
        "date": "2026-04-09 08:28:35",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 April 2026. This change reflects a deterioration in technical indicators despite the company’s positive quarterly financial performance and long-term market-beating returns. Investors are advised to weigh the mixed signals from quality, valuation, financial trends, and technicals before making decisions."
      },
      {
        "title": "Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-upgraded-to-hold-as-technicals-improve-and-valuation-attracts-3933377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_mojoScore_3933377.png",
        "date": "2026-04-03 08:14:51",
        "description": "Haleos Labs Limited has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, reflecting a notable shift in technical indicators and valuation metrics. Despite some lingering concerns over long-term fundamentals, the company’s recent financial performance and market behaviour have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Haleos Labs Limited Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-upper-circuit-amid-strong-buying-pressure-3928914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_stocks_hitting_upper_circuit_3928914.png",
        "date": "2026-04-01 11:00:23",
        "description": "At Rs 1,253.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Haleos Labs Limited locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Haleos Labs Limited Downgraded to Sell Amid Mixed Financials and Technical Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-downgraded-to-sell-amid-mixed-financials-and-technical-weakness-3917690",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HaleosLabsLimit_mojoScore_3917690.png",
        "date": "2026-03-26 08:13:14",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 March 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation challenges despite some positive quarterly performance. The downgrade underscores growing caution among investors amid mixed signals across key assessment parameters."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-3893359",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HaleosLabsLimit_mojoScore_3893359.png",
        "date": "2026-03-16 10:10:02",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 4 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-upgraded-to-hold-as-technicals-improve-and-valuation-attracts-3872894",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HaleosLabsLimit_mojoScore_3872894.png",
        "date": "2026-03-05 08:31:10",
        "description": "Haleos Labs Limited, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This revision reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, signalling a cautious but more optimistic outlook for investors amid mixed fundamental signals."
      },
      {
        "title": "Haleos Labs Limited is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-sell-3857770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HaleosLabsLimit_mojoScore_3857770.png",
        "date": "2026-02-26 10:10:50",
        "description": "Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-by-marketsmojo-3839063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HaleosLabsLimit_mojoScore_3839063.png",
        "date": "2026-02-14 10:10:31",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 438,
    "sid": "1002809",
    "stock_news_url": "https://www.marketsmojo.com/news/haleos-labs-limited-1002809"
  },
  "announcements": [
    {
      "caption": "Annual Confirmation (Reclassification)",
      "datetime": "08-Apr-2026",
      "details": "Confirmation received from the erstwhile Promoter group.",
      "source": "BSE"
    },
    {
      "caption": "Encumbrance (Annual Disclosure)",
      "datetime": "08-Apr-2026",
      "details": "Disclosure related to the non-encumbrance of shares received from promoters.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Enclosed - RTA certificate.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Haleos Labs Limited has declared <strong>15%</strong> dividend, ex-date: 24 Sep 25",
          "dt": "2025-09-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts

2026-04-14 08:42:09

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 13 April 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors.

Read full news article

Haleos Labs Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-04-09 08:28:35

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 April 2026. This change reflects a deterioration in technical indicators despite the company’s positive quarterly financial performance and long-term market-beating returns. Investors are advised to weigh the mixed signals from quality, valuation, financial trends, and technicals before making decisions.

Read full news article

Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts

2026-04-03 08:14:51

Haleos Labs Limited has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, reflecting a notable shift in technical indicators and valuation metrics. Despite some lingering concerns over long-term fundamentals, the company’s recent financial performance and market behaviour have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Haleos Labs Limited Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-04-01 11:00:23

At Rs 1,253.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Haleos Labs Limited locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Haleos Labs Limited Downgraded to Sell Amid Mixed Financials and Technical Weakness

2026-03-26 08:13:14

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 March 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation challenges despite some positive quarterly performance. The downgrade underscores growing caution among investors amid mixed signals across key assessment parameters.

Read full news article

Haleos Labs Limited is Rated Hold

2026-03-16 10:10:02

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 4 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts

2026-03-05 08:31:10

Haleos Labs Limited, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This revision reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, signalling a cautious but more optimistic outlook for investors amid mixed fundamental signals.

Read full news article

Haleos Labs Limited is Rated Sell

2026-02-26 10:10:50

Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Haleos Labs Limited is Rated Hold by MarketsMOJO

2026-02-14 10:10:31

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

View All News